Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2553 of 6351
-
New balloon and laser combo may save legs and money
Disease control CompletedThe aim of this multicenter triple-arm randomized study is to compare two innovative techniques with the gold standard currently used and providing unsatisfactory results for the In-Stent Restenosis (ISR) treatment in femoro-popliteal arteries. This protocol compares the use of d…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
MRI scans for pacemaker patients: no special vetting needed?
Knowledge-focused By invitation onlyFerromagnetic Implants such as permanent pacemakers (PPM's) and Implantable Cardioverter Defibrillators (ICD's) have traditionally been accepted as contraindications to Magnetic Resonance Imaging (MRI) due to safety concerns. Over the past several years, MRI safety has been estab…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Pancreatic cancer gene map could lead to smarter treatments
Knowledge-focused CompletedResearchers are looking for better ways of understanding and treating pancreatic cancer. The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cell…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Gene-Matching trial aims to outsmart cancer by pairing mutations with drugs
Knowledge-focused Recruiting nowThis is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease. In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling. Patients includ…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Humira shows promise for Long-Term control of Kids' colitis
Disease control CompletedThis study assesses the long-term safety and efficacy of adalimumab in pediatric subjects with ulcerative colitis.
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Scientists hunt for clues to stop cancer weight loss
Knowledge-focused CompletedOne way cancer affects people is through weight loss. During this weight loss (called cachexia), all types of body tissue are lost, but there is a greater rate of muscle loss than fat. Cancer patients with cachexia show decreased quality of life, decreased response to treatment (…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Botox shots for bowel control: a new hope for fecal incontinence?
Symptom relief CompletedFecal incontinence is a frequent pathology which concerns 10% of the general population and severely alters patients quality of life. The cost of urinary and faecal incontinence has been estimated to be $16 billions a year. Several treatments exist depending on the aetiology of t…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
AI may predict ulcerative colitis severity before a scope — a study puts it to the test
Knowledge-focused OngoingThis multicenter retrospective observational study aims to develop and externally validate a machine learning model that predicts Montreal ulcerative colitis (UC) disease extent (E1: limited/proctitis; E2: left-sided; E3: extensive) using pre-endoscopic clinical information, incl…
Sponsor: Beijing University of Chinese Medicine • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Targeted drug shows promise for rare NF2-Mutated cancers
Disease control OngoingThis phase II MATCH treatment trial identifies the effects of VS-6063 (defactinib) in patients whose cancer has a genetic change called NF2 mutation. Defactinib may block a protein called FAK, which may be needed for cancer cell growth when NF2 mutations are present. Researchers …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New PET scan aims to spot hidden cancers with precision
Diagnosis OngoingThis pilot clinical trial studies copper Cu 64 anti-carcinoembryonic antigen (CEA) monoclonal antibody M5A positron emission tomography (PET) in diagnosing patients with CEA positive cancer. Diagnostic procedures, such as copper Cu 64 anti-CEA monoclonal antibody M5A PET, may hel…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New chemo combo tested for rare gut cancers – results disappoint
Disease control OngoingThis randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that has spread to other part…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
15-Year study tracks hidden risks of CAR-T cancer therapy
Knowledge-focused Recruiting nowPer Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CAR-T therapi…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Can a common cough drug dampen pain sensitivity?
Knowledge-focused CompletedThe aim of this study is to assess the anti-hyperalgesic effect of dextromethorphan in healthy volunteers compared to placebo.
Phase 1 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Face mask zaps nerve pain: new hope for trigeminal neuralgia?
Symptom relief OngoingTo determine the feasibility of frameless Virtual Cone trigeminal neuralgia radiosurgery at a single institution prior to multi-institutional enrollment.
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New blood thinner may shield heart during artery procedure
Disease control CompletedRotational atherectomy (RA) prior to angioplasty is the reference treatment for highly calcified atherosclerotic coronary lesions. It aims at fragmenting calcium deposits into microscopic particulates to allow less hazardous coronary revascularization and stenting. The main drawb…
Phase 4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a diabetes shot shield heart and kidneys? new study investigates.
Disease control CompletedAmong adult individuals with type 2 diabetes mellitus and at risk for heart failure with impaired relaxation of the heart mildly reduced kidney filtration function (Type 4 cardiorenal syndrome) this trial will evaluate the quantitative impact of 38 weeks of treatment with exenati…
Phase 3 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
One extra shot around embryo transfer may lift IVF live birth rates
Disease control Recruiting nowDuring IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to …
Phase 4 • Sponsor: University Reproductive Associates • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Robots teach kids with autism to read emotions
Symptom relief CompletedThis study is being done to examine the impact of an interactive, social robotics program in helping children with autism spectrum disorders (ASD) understand emotions and how to better recognize emotions while interacting with others. Eligible families will be randomized to eithe…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 19:05 UTC
-
Can a pill speed up hip fracture recovery in seniors?
Disease control CompletedThis is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to investigate the safety, tolerability, and efficacy of VK5211 after 12 weeks of treatment. Males and females ≥65 years old who are ambulatory and recovering from a hip fracture will be el…
Phase 2 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control Stopped earlyThis phase I trial studies the side effects and best dose of nivolumab when given with ipilimumab in treating patients with human immunodeficiency virus (HIV) associated classical Hodgkin lymphoma that has returned after a period of improvement (relapsed) or does not respond to t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC